| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Driscoll Frederick W serves as a Director at IBRX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 2 buys and 4 sells. Those positions are worth an estimated $1.3M at current prices.
The biggest single holding is IBRX (~$1.2M) as Director. The recent filings there lean toward selling, a net 65,300 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | CLRB Cellectar Biosciences, Inc. | Director | Buy | 19,417 | $1.04 | $20,244.16 | New | -36.3% | -49.1% | |
| Feb 23, 2021 | LITS Lite Strategy, Inc. | Director | Sell | 25,000 | $4.03 | $100,625.00 | -40.0% | - | - | |
| Aug 11, 2020 | IBRX Immunitybio, Inc. | Director | Sell | 65,300 | $10.23 | $668,051.57 | -37.4% | - | - | |
| Dec 19, 2019 | LITS Lite Strategy, Inc. | Director | Buy | 62,500 | $1.60 | $100,000.00 | New | - | - |